BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+57.97%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.28B
AUM Growth
+$1.28B
(+50%)
Cap. Flow
-$142K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$2.01M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$2.15M |
Sector Composition
| 1 | Healthcare | 56.68% |
| 2 | Consumer Staples | 25.23% |
| 3 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $665M | 51.95% | 10,799,410 | – | – |
|
2
Monster Beverage
MNST
$60.9B
| $323M | 25.23% | 4,656,488 | – | – |
|
|
3
iShares Russell 2000 ETF
IWM
$67B
| $157M | 12.26% | 1,095,000 -15,000 | -1% | -$2.15M |
|
4
Axon Enterprise
AXON
$58.7B
| $74.6M | 5.83% | 760,062 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $29.6M | 2.31% | 34,005,379 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $28.1M | 2.2% | 14,716,204 +1,050,000 | +8% | +$2.01M |
|
7
Serina Therapeutics
SER
$54.5M
| $2.84M | 0.22% | 2,997,156 | – | – |
|